An 88-year-old man with hypertension, dyslipidemia, mild glucose intolerance, and chronic kidney disease (eGFR ~40 ml/min) was reassessed for known wild-type transthyretin cardiac amyloidosis (ATTRwt) , diagnosed in 2022 after an initial episode of heart failure. The patient remained clinically stable and currently reports no exertional dyspnea, consistent with…